GET THE APP

Radiation Therapy for Lung Cancer in Elderly Patients: Balancing Risks and Benefits
..

Journal of Lung Diseases & Treatment

ISSN: 2472-1018

Open Access

Commentary - (2023) Volume 9, Issue 3

Radiation Therapy for Lung Cancer in Elderly Patients: Balancing Risks and Benefits

Miyamichi Stephen*
*Correspondence: Miyamichi Stephen, Department of Radiation Oncology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube 755-8505, Yamaguchi, Japan, Email:
Department of Radiation Oncology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube 755-8505, Yamaguchi, Japan

Received: 01-May-2023, Manuscript No. LDT-23-116539; Editor assigned: 03-May-2023, Pre QC No. P-116539; Reviewed: 17-May-2023, QC No. Q-116539; Revised: 23-May-2023, Manuscript No. R-116539; Published: 30-May-2023 , DOI: 10.37421/2472-1018.2023.9.188
Citation: Stephen, Miyamichi. “Radiation Therapy for Lung Cancer in Elderly Patients: Balancing Risks and Benefits.” J Lung Dis Treat 9 (2023): 188.
Copyright: © 2023 Stephen M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Radiation therapy is a key component of the multidisciplinary approach to lung cancer management. It involves the use of high-energy X-rays or other forms of radiation to target and destroy cancer cells. Radiation therapy can be administered with curative intent, aiming to eliminate the cancer, or palliatively, to alleviate symptoms and improve the patient's quality of life. In elderly patients with lung cancer, radiation therapy is often utilized to address a range of concerns, including symptom management, local tumor control and potential cure. Lung cancer is a significant public health concern worldwide and its impact is particularly pronounced in the elderly population. While advancements in cancer treatment have made significant strides, the management of lung cancer in older patients poses unique challenges. Radiation therapy, a cornerstone of lung cancer treatment, offers hope for many elderly individuals, but it also requires a delicate balance between the potential benefits and the associated risks.

Lung cancer is a disease primarily associated with aging and as the global population continues to age, the prevalence of lung cancer among elderly patients is on the rise. Elderly patients often present with different characteristics than their younger counterparts, including a higher prevalence of comorbidities and reduced functional reserves. These factors complicate the treatment decision-making process, making it essential to tailor lung cancer therapies to meet the specific needs of elderly individuals. Radiation therapy offers substantial benefits in the treatment of lung cancer, but it is not without risks. For elderly patients, a careful assessment of the potential advantages and drawbacks is vital in making treatment decisions [1].

Description

Radiation therapy can effectively shrink or eradicate tumors, providing relief from cancer-related symptoms and improving overall survival. The potential for local tumor control can significantly enhance the quality of life for elderly patients. Elderly patients often have other health issues, such as heart disease, diabetes, or Chronic Obstructive Pulmonary Disease (COPD). Radiation therapy can exacerbate some of these comorbidities, leading to potential complications. A decline in functional status and reduced mobility is common among the elderly. Radiation therapy can contribute to fatigue and physical decline, impacting the patient's ability to carry out daily activities. Elderly patients may be more susceptible to the side effects of radiation therapy. Radiodermatitis, esophagitis and radiation pneumonitis can be more severe in this population [2].

Assessing the patient's overall health and functional status is essential. Treatment plans should be tailored to the individual's ability to tolerate therapy and potential side effects. The stage, location and size of the tumor should be evaluated to determine the potential benefit of radiation therapy. A thorough evaluation of existing health conditions is necessary to understand the potential impact of radiation therapy on these comorbidities. Understanding the patient's values, goals and preferences is crucial. Some elderly individuals may prioritize quality of life over aggressive treatment. Involving a multidisciplinary team, including oncologists, radiation oncologists, pulmonologists and geriatric specialists, can provide a more comprehensive assessment of the patient's needs and guide the treatment plan [3].

Radiation therapy is a valuable tool in the management of lung cancer in elderly patients, but it requires a thoughtful and individualized approach. Balancing the risks and benefits is essential to make informed treatment decisions. The goal is not just to extend life but to improve the quality of life for elderly individuals facing this challenging diagnosis. Through shared decisionmaking and careful consideration of the unique characteristics of each patient, we can strive to achieve the best possible outcome for elderly lung cancer patients while maintaining their well-being and dignity. In addition to considering the risks and benefits of radiation therapy, it's important to address the supportive care needs of elderly lung cancer patients. Palliative care, which focuses on alleviating symptoms and improving the overall quality of life, plays a crucial role in the management of this population. Palliative radiation therapy can help manage symptoms such as pain, shortness of breath and cough, providing relief even for patients who may not be candidates for curative treatment [4].

Elderly patients with lung cancer may experience pain related to tumor invasion or metastasis. Palliative radiation therapy can help alleviate pain and improve the patient's comfort. Shortness of breath is a common symptom of lung cancer, particularly in elderly individuals. Radiation therapy can be used to target and shrink tumors in the airways, reducing symptoms and improving breathing. Persistent cough can be distressing for lung cancer patients. Palliative radiation therapy can help in reducing cough severity and frequency, enhancing the patient's quality of life. For patients with advanced lung cancer and limited life expectancy, discussions about end-of-life care and hospice services are important. These conversations should be conducted with sensitivity and respect for the patient's values and wishes [5].

Conclusion

To better inform treatment decisions for elderly lung cancer patients, geriatric assessment tools can be valuable. These assessments evaluate various domains, including functional status, comorbidities, cognition, psychological well-being and social support. They help identify potential areas of vulnerability and tailor treatment plans accordingly. Incorporating a geriatric assessment into the decision-making process can provide a more comprehensive understanding of the patient's overall health and functioning, ultimately guiding treatment choices that are more in line with the individual's needs and preferences. The management of lung cancer in elderly patients through radiation therapy requires a balanced approach that carefully weighs the potential benefits against the associated risks. Each patient is unique and treatment decisions should be individualized, taking into account performance status, tumor characteristics, comorbidities, patient preferences and the guidance of a multidisciplinary team. Additionally, palliative care and supportive measures play a crucial role in improving the quality of life for elderly patients, even in cases where curative treatment may not be a viable option. With a focus on patient-centered care, we can strive to provide the best possible outcomes while preserving the dignity and well-being of elderly lung cancer patients.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

  1. Davis, Faith G., Therese A. Dolecek, Bridget J. McCarthy and John L. Villano. "Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data." J Neurooncol 14 (2012): 1171-1177.
  2. Google Scholar, Crossref, Indexed at

  3. Tabouret, Emeline, Luc Bauchet and Antoine F. Carpentier. "Brain metastases epidemiology and biology." Bull du Cancer 100 (2013): 57-62.
  4. Google Scholar, Crossref, Indexed at

  5. Postow, Michael A., Margaret K. Callahan, Christopher A. Barker and Yoshiya Yamada, et al. "Immunologic correlates of the abscopal effect in a patient with melanoma." N Engl J Med 366 (2012): 925-931.
  6. Google Scholar, Crossref, Indexed at

  7. Zscheppang, Katja, Johanna Berg, Sarah Hedtrich and Leonie Verheyen, et al. "Human pulmonary 3D models for translational research." Biotechnol J 13 (2018): 1700341.
  8. Google Scholar, Crossref, Indexed at

  9. Hofmann, Falk, Robert Bläsche, Michael Kasper and Kathrin Barth. "A co-culture system with an organotypic lung slice and an immortal alveolar macrophage cell line to quantify silica-induced inflammation." PLoS One 10 (2015): e0117056.
  10. Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward